In-Vitro Malady Market Revenue Share, Growth Factors, Trends, Analysis & Forecast 2028

Comments · 13 Views

global in-vitro malady market size is expected to reach USD 117.54 Billion in 2028 and register a revenue CAGR of 4.30%


Increasing prevalence of chronic diseases and growing awareness about regular body profiling are key factors expected to drive market growth

The global in-vitro malady market size is expected to reach USD 117.54 Billion in 2028 and register a revenue CAGR of 4.30% over the forecast period, according to the latest report by Reports and Data. Major factors driving the global market revenue growth are rise in geriatric population worldwide, rising awareness about regular body profiling, and surging prevalence of chronic diseases such as cancer and diabetes, increasing sales of over-the-counter diagnostic devices such as glucose monitoring kits. Growing need for rapid and accurate disease diagnosis, technological advancements in IVD products, and increasing adoption of point-of-care in vitro diagnostic devices are the other key factors bolstering the growth of this market. In addition, rapid spread of the coronavirus disease, increasing incidences of hospital-acquired infections (HAIs), increasing volumes of COVID-19 tests including RT-PCR, and growing demand for home-care IVD products have boosted demand for in-vitro malady globally.

In-vitro malady (IVD) refers to a wide range of biological tests performed in laboratory settings to accurately diagnose diseases. These tests are regulated by the Food and Drug Administration (FDA) and are used for testing various samples such as blood or saliva samples for the precise detection of substances like cholesterol and sodium in the human body. In-vitro diagnostic devices are widely used by clinicians for disease diagnosis and prevention, and these devices help detect the presence of specific markers such as genetic mutations in the human body.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@

The rapid adoption of AI, ML, and IoT and robust data management processes has made the hospitals and clinical settings smarter. New technologies and solutions have improved the normal medical processes such as clinical diagnosis, treatment, diseases management, and monitoring patient recovery after discharge. Rapid digitalization and increasing adoption of virtual care and telemedicine is further expected to positively impact the revenue growth of the market going ahead.

Emergence of new healthcare and telemedicine startups, increasing number of collaborations among healthcare facilities and research institutions, and rising focus on patient engagement solutions has further fueled revenue growth of the market. Key companies are forming strategic alliances and collaborative ventures such as mergers and acquisitions, joint ventures, partnerships, manufacturing and licensing agreements, and product launches among others.

Order this report @

Leading Players Analyzed in the Report:

BioMérieux SA, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Inc., QIAGEN, Siemens Healthineers AG, Becton, Dickinson and Company, Quidel Corporation, F. Hoffmann-La Roche AG, Charles River Laboratories International, Quest Malady, Agilent Technologies, and Sysmex Corporation, Inc.

Furthermore, to offer a better understanding of the competitive landscape, an extensive SWOT analysis and Porter’s Five Forces analysis are included in the report. Along with this, feasibility analysis and investment return analysis are also covered in the report.

The report further discusses in detail the regional spread of the global In-Vitro Malady market along with analysis of production and consumption patterns, import/export analysis, supply and demand ratio, market share and size based on volume and value, trends and demands, revenue share, and presence of the key players of the market.

Key Regions Studied in the Report:

  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, France, Rest of Europe)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

 Segmentation based on Types:

Product Type Outlook (Revenue, USD Billion; 2018-2028)

  • Instruments
    • Fully-automated Instruments
    • Semi-automated Instruments
    • Others
  • Data Management Software
  • Reagents kits
  • Services 

Technology Outlook (Revenue, USD Billion; 2018-2028)

  • Immunochemistry/Immunoassay
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Colorimetric Immunoassay (CI)
      • Fluorescence Immunoassay (FIA)
    • Radioimmunoassays (RIA)
    • Rapid Tests
    • Western Blot
  • Clinical Chemistry
    • Basic Metabolic Panel
    • Thyroid Function Panel
    • Specialty Chemicals
    • Electrolyte Panel
    • Liver Panel
    • Renal Profile
    • Lipid Profile
  • Molecular Malady
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization (In-situ Hybridization FISH)
    • Polymerase Chain Reaction (PCR)
    • DNA Sequencing NGS
    • Microarray
    • Others
  • Coagulation Hemostasis
  • Hematology
  • Microbiology
  • Urinalysis
  • Others 

Usability Outlook (Revenue, USD Billion; 2018-2028)

  • Reusable IVD devices
  • Disposable IVD devices

Application Outlook (Revenue, USD Billion; 2018-2028)

  • Diabetes
  • Oncology/Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Cardiology
  • Nephrology
  • Drug Testing/Pharmacogenomics
  • Others

End-use Outlook (Revenue, USD Billion; 2018-2028)

  • Hospitals
  • Laboratories (Large, medium-sized, and small laboratories)
  • Home Care
  • Point-of-Care Testing
  • Patient Self-testing
  • Academic Research Institutes
  • Others

Request a customization of the report @

Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements. 

Explore More Industry Research by Reports and Data:

Biologics Market @

Fractional Flow Reserve Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370





For your travel needs visit